Forus, Inc.

Forus, Inc. , based in the US, specializes in automating prior authorization processes for medications, enhancing efficiency for healthcare providers while improving patient access to necessary treatments. Forus, Inc. was founded in 2023 and is headquartered in New York, US.

The company operates a platform originally known as Tandem, which focuses on automating the prescription approval process. Forus has successfully completed one funding round, raising USD 160. 00 mn from investors including Accel, Bain Capital, BoxGroup, General Catalyst Partners, Pear VC, Redpoint Ventures, and Thrive Capital as of May 12, 2026, marking a significant milestone in its growth. Forus offers a comprehensive platform that automates the entire prior authorization process for medications, supporting a wide range of drugs, insurance plans, and pharmacies across all 50 states.

This solution alleviates the burden of paperwork and communication for healthcare providers, enabling them to focus more on patient care. The user base includes thousands of healthcare professionals, from independent practitioners to large health systems, who benefit from real-time visibility into medication approval processes. Forus employs a business model that provides its services at no cost to healthcare providers and patients. This structure allows the company to facilitate transactions through partnerships with healthcare providers who integrate Forus into their existing electronic health record (EHR) systems.

The platform enhances operational efficiencies by automating prior authorization processes while ensuring compliance with HIPAA regulations. Following the recent funding round in May 2026, Forus will utilize the USD 160. 00 mn raised to develop and scale its AI-powered network, which automates insurance authorization, financial assistance, and prescription fulfillment among doctors, pharmacies, payers, and biopharma companies. The company is focused on expanding its offerings and enhancing its platform capabilities to improve healthcare accessibility and efficiencies.